This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of pharmaceutical agents. It is often investigated for its potential as a modulator of biological targets, such as receptors or enzymes, due to its unique structural properties. The trifluoromethyl groups enhance its binding affinity and metabolic stability, making it a promising candidate for drug discovery. Researchers explore its applications in treating conditions like neurological disorders, cancer, or inflammatory diseases, where it may act as an inhibitor or activator of specific pathways. Its chiral cyclohexyl moiety also allows for selective interactions with biological systems, contributing to its efficacy and specificity in therapeutic applications.